A major conference that took place earlier this month is set to return to San Francisco next year, according to SF Mayor Daniel Lurie’s office. The J.P. Morgan Healthcare Conference was held in the ...

Health care executives continue to reimagine and reshape their organizations. Their ideas were developing in real time during ...

This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...

What does Trump's decision to leave the WHO mean for public health? And should U.S. companies be intimidated by Chinese drug ...

The desire of digital health companies to scale through mergers and acquisitions or partnerships was one of the most ...

Healthcare leaders shared insights on various topics, including industry challenges, a new administration and growing their ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

While some analysts expect the 2025 IPO market to be relatively cool in the near-term, others anticipate more bids than in ...

Biopharma executives make their predictions for the year ahead, from a bold forecast for the return of the megadeal to a plea ...

Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic priorities for the year 2025 and anticipated milestones in a recent press release on ...

San Francisco law enforcement and city leaders are gearing up for a big month ahead and are warning people to be on alert for ...